Rare Diseases Clinical Research Network

Results: 64



#Item
1Rare Diseases Clinical Research Network (RDCRN) Publications Updated: July 11, 2018 RDCRN Data Management and Coordinating Center Publications DMCC Publications

Rare Diseases Clinical Research Network (RDCRN) Publications Updated: July 11, 2018 RDCRN Data Management and Coordinating Center Publications DMCC Publications

Add to Reading List

Source URL: www.rarediseasesnetwork.org

Language: English - Date: 2018-08-14 09:16:23
    2DENISE SHEREFF, MLIS, AHIP University of South Florida School of Information4202 E. Fowler Ave., CIS 1040

    DENISE SHEREFF, MLIS, AHIP University of South Florida School of Information4202 E. Fowler Ave., CIS 1040

    Add to Reading List

    Source URL: si.usf.edu

    Language: English - Date: 2015-09-30 14:05:00
    3Rare Diseases Clinical Research Network (RDCRN) Publications Updated: August 1, 2016 RDCRN Data Management and Coordinating Center Publications DMCC Publications

    Rare Diseases Clinical Research Network (RDCRN) Publications Updated: August 1, 2016 RDCRN Data Management and Coordinating Center Publications DMCC Publications

    Add to Reading List

    Source URL: www.rarediseasesnetwork.org

    Language: English - Date: 2016-08-05 12:49:27
    4AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu

    AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu

    Add to Reading List

    Source URL: www.ccrm.ca

    Language: English - Date: 2016-02-18 12:07:01
    5Update on Nephrolithiasis Part 2: Risk for Recurrent Stones and Search for Rare Causes of Kidney Stones

    Update on Nephrolithiasis Part 2: Risk for Recurrent Stones and Search for Rare Causes of Kidney Stones

    Add to Reading List

    Source URL: www.mayomedicallaboratories.com

    Language: English - Date: 2015-05-14 17:39:18
    6July, 2014 DAVID E. BIEGEL CURRICULUM VITAE TITLE David E. Biegel, Ph.D. Henry Zucker Professor of Social Work Practice

    July, 2014 DAVID E. BIEGEL CURRICULUM VITAE TITLE David E. Biegel, Ph.D. Henry Zucker Professor of Social Work Practice

    Add to Reading List

    Source URL: socialwork.case.edu

    Language: English - Date: 2014-12-11 13:28:24
    7VITA June 2010 PERSONAL INFORMATION Name: Office Addresses:

    VITA June 2010 PERSONAL INFORMATION Name: Office Addresses:

    Add to Reading List

    Source URL: www.annenbergpublicpolicycenter.org

    Language: English - Date: 2010-08-06 09:06:40
    8Downloaded from adc.bmj.com on February 9, [removed]Published by group.bmj.com  Rare childhood diseases: how should we respond? Y Zurynski, K Frith, H Leonard, et al. Arch Dis Child[removed]: [removed]originally published

    Downloaded from adc.bmj.com on February 9, [removed]Published by group.bmj.com Rare childhood diseases: how should we respond? Y Zurynski, K Frith, H Leonard, et al. Arch Dis Child[removed]: [removed]originally published

    Add to Reading List

    Source URL: www.apsu.org.au

    Language: English - Date: 2012-12-26 17:49:20
    9SPEAKERS Christopher P. Austin, M.D., is the director of pre-clinical innovation at the National Center for Advancing Translational Sciences, a new center at the National Institute of Health; its purpose is to speed the

    SPEAKERS Christopher P. Austin, M.D., is the director of pre-clinical innovation at the National Center for Advancing Translational Sciences, a new center at the National Institute of Health; its purpose is to speed the

    Add to Reading List

    Source URL: events-support.com

    Language: English - Date: 2012-06-13 12:26:45
    10WORKSHOP SUMMARY Sponsored by: Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) Office of the Commissioner, Office of Orphan Products Development (OOPD), FDA National Institutes of Healt

    WORKSHOP SUMMARY Sponsored by: Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) Office of the Commissioner, Office of Orphan Products Development (OOPD), FDA National Institutes of Healt

    Add to Reading List

    Source URL: events-support.com

    Language: English - Date: 2012-06-15 15:38:24